Halda HLD-0915-ONC-101 for metastatic APMS Prostate Cancer - Clinical Trial

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
Phase 1/2 Study of HLD-0915 (JNJ-101556143) in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Principal Investigator
Dillon Cockrell, MD
Medical Oncologist
Protocol Number
IRB: PRO00118104
NCT: NCT06800313
Phase
Phase I/II
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Support Duke Health research or honor a loved one with a tribute gift.
Giving to Duke Health